glp 1 agonist drug Evolution of GLP‐1 Receptor Agonists for Diabetes Treatment glp-1_analogs [TUSOM | Pharmwiki]

Chemical Information: Compound Name: IGF-1 DES (Insulin-like Growth Factor-1 DES)

Deleterious off-target effects in women 10 years or more past menopause, such as ovarian, endometrial, and breast cancers, intravascular thrombosis, cardiovascular episodes, and stroke, and suppression of endogenous testosterone and libido and increased risk of prostate cancer in men, have precluded broad clinical applications (Hall and Phillips, 2005

This makes them out of reach for many people, especially for long-term use

The most studied preclinical doses are 10 g/kg and 10 ng/kg administered subcutaneously, intraperitoneally, or orally

Together, these findings suggest that KYN-driven oxidative stress is not merely an epiphenomenon of depression but a mechanistic contributor to mitochondrial dysfunction, neuroprogression, and systemic comorbidity, highlighting redox modulation as a critical interface between inflammation, KP activity, and depressive pathology